Seeing the cricket has been terrible I decided to put my head...

Seeing the cricket has been terrible I decided to put my head into whom possibly could we be collaborating with for the Immune-oncology work.

I just want to make this very clear that this is all speculation and stupidly I find this kind of research fun.
We can all remember the Frazer video that was pulled from YouTube I posted a while back, I had taken notes from this and one thing that was brought to my attention was the work and colleagues that Prof Ian Frazer did on the new HPV vaccine.

Now Prof Frazer stated that they would like to use the IDO inhibitor path for this new treatment, and the colleague behind that work was a man called Deepak Mittal.

Trial research notes and Info - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3779505/

You can see in this trial info that the use of the IDO Inhibitor was purchased from Sigma-Aldrich

Sigma-Aldrich (1-D-MT) - http://www.sigmaaldrich.com/catalog/papers/21625531

Info on Deepak Mittal can be found here - http://getfiles.qimr.edu.au/apcmeeting/A&P%20papers%20Day%202.pdf

Now Deepak was also sponsored at one stage by Bristol-Myers-Squibb and guess what info I found
http://www.fiercebiotech.com/financials/updated-bristol-myers-bags-ido-immunotherapy-1-25b-buyout-of-fledgling-flexus
http://bms.newshq.businesswire.com/press-release/rd-news/bristol-myers-squibb-expand-its-immuno-oncology-pipeline-agreement-acquire-fle
http://www.pmlive.com/pharma_news/bms_buys_immunotherapy_specialist_flexus_in_$1.2bn_deal_661058

So Bristol-Myers-Squibb has recently spent a tonne of money to purchase possibly the best IDO inhibitor to crack the immune-oncology market.

This is currently in trial, so perhaps were waiting on their work? Now keeping in mind this isn’t the only IDO inhibitor in trials.

The key for our work to begin is having the best IDO inhibitor money can buy….

And as I said, this is just pure speculation.